These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 23489096

  • 1. GPR119 agonists as potential new oral agents for the treatment of type 2 diabetes and obesity.
    Fyfe MC, McCormack JG, Overton HA, Procter MJ, Reynet C.
    Expert Opin Drug Discov; 2008 Apr; 3(4):403-13. PubMed ID: 23489096
    [Abstract] [Full Text] [Related]

  • 2. The therapeutic potential of GPR119 agonists for type 2 diabetes.
    Ohishi T, Yoshida S.
    Expert Opin Investig Drugs; 2012 Mar; 21(3):321-8. PubMed ID: 22292451
    [Abstract] [Full Text] [Related]

  • 3. GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders.
    Shah U, Kowalski TJ.
    Vitam Horm; 2010 Mar; 84():415-48. PubMed ID: 21094910
    [Abstract] [Full Text] [Related]

  • 4. GPR119 agonists: a promising new approach for the treatment of type 2 diabetes and related metabolic disorders.
    Shah U.
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):519-32. PubMed ID: 19562648
    [Abstract] [Full Text] [Related]

  • 5. GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity.
    Overton HA, Fyfe MC, Reynet C.
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S76-81. PubMed ID: 18037923
    [Abstract] [Full Text] [Related]

  • 6. N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119.
    Chu ZL, Carroll C, Chen R, Alfonso J, Gutierrez V, He H, Lucman A, Xing C, Sebring K, Zhou J, Wagner B, Unett D, Jones RM, Behan DP, Leonard J.
    Mol Endocrinol; 2010 Jan; 24(1):161-70. PubMed ID: 19901198
    [Abstract] [Full Text] [Related]

  • 7. GPR119 agonists for the treatment of type 2 diabetes: an updated patent review (2014-present).
    Li H, Fang Y, Guo S, Yang Z.
    Expert Opin Ther Pat; 2021 Sep; 31(9):795-808. PubMed ID: 33896337
    [Abstract] [Full Text] [Related]

  • 8. The significance of GPR119 agonists as a future treatment for type 2 diabetes.
    Dhayal S, Morgan NG.
    Drug News Perspect; 2010 Sep; 23(7):418-24. PubMed ID: 20862393
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: focus on bile acid sequestrants.
    Holst JJ, McGill MA.
    Clin Drug Investig; 2012 Jan 01; 32(1):1-14. PubMed ID: 21958333
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bidirectional GPR119 Agonism Requires Peptide YY and Glucose for Activity in Mouse and Human Colon Mucosa.
    Tough IR, Forbes S, Herzog H, Jones RM, Schwartz TW, Cox HM.
    Endocrinology; 2018 Apr 01; 159(4):1704-1717. PubMed ID: 29471473
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ.
    J Am Pharm Assoc (2003); 2009 Apr 01; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119.
    Hassing HA, Fares S, Larsen O, Pad H, Hauge M, Jones RM, Schwartz TW, Hansen HS, Rosenkilde MM.
    Biochem Pharmacol; 2016 Nov 01; 119():66-75. PubMed ID: 27569424
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system.
    Vergès B, Bonnard C, Renard E.
    Diabetes Metab; 2011 Dec 01; 37(6):477-88. PubMed ID: 21871831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.